Literature DB >> 15231557

Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine.

Jacob Alexander1, Prathap Tharyan, Clive Adams, Thomas John, Carina Mol, Joncy Philip.   

Abstract

BACKGROUND: The pharmacological management of violence in people with psychiatric disorders is under-researched. AIMS: To compare interventions commonly used for controlling agitation or violence in people with serious psychiatric disorders.
METHOD: We randomised 200 people to receive intramuscular lorazepam (4 mg) or intramuscular haloperidol (10 mg) plus promethazine (25-50 mg mix).
RESULTS: At blinded assessments 4 h later (99.5% follow-up), equal numbers in both groups (96%) were tranquil or asleep. However, 76% given the haloperidol-promethazine mix were asleep compared with 45% of those allocated lorazepam (RR=2.29,95% CI 1.59-3.39; NNT=3.2,95% CI 2.3-5.4). The haloperidol-promethazine mix produced a faster onset of tranquillisation/sedation and more clinical improvement over the first 2 h. Neither intervention differed significantly in the need for additional intervention or physical restraints, numbers absconding, or adverse effects.
CONCLUSIONS: Both interventions are effective for controlling violent/agitated behaviour. If speed of sedation is required, the haloperidol-promethazine combination has advantages over lorazepam.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231557     DOI: 10.1192/bjp.185.1.63

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  33 in total

1.  Organisational interventions for preventing and minimising aggression directed towards healthcare workers by patients and patient advocates.

Authors:  Evelien Spelten; Brodie Thomas; Peter F O'Meara; Brian J Maguire; Deirdre FitzGerald; Stephen J Begg
Journal:  Cochrane Database Syst Rev       Date:  2020-04-29

Review 2.  Cochrane Schizophrenia Group.

Authors:  Clive E Adams; Evandro S F Coutinho; John Davis; Lorna Duggan; Stefan Leucht; Chunbo Li; Prathap Tharyan
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

Review 3.  Methodological issues in current antipsychotic drug trials.

Authors:  Stefan Leucht; Stephan Heres; Johannes Hamann; John M Kane
Journal:  Schizophr Bull       Date:  2008-01-29       Impact factor: 9.306

Review 4.  [Psychotropic agents in emergency medicine].

Authors:  A Wolf; M J Müller; F-G B Pajonk
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-02       Impact factor: 0.840

Review 5.  Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).

Authors:  Edoardo G Ostinelli; Melanie J Brooke-Powney; Xue Li; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

Review 6.  2C or not 2C: phenethylamine designer drug review.

Authors:  Be Vang Dean; Samuel J Stellpflug; Aaron M Burnett; Kristin M Engebretsen
Journal:  J Med Toxicol       Date:  2013-06

7.  Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine.

Authors:  Gisele Huf; E S F Coutinho; C E Adams
Journal:  BMJ       Date:  2007-10-22

8.  Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine.

Authors:  Nirmal S Raveendran; Prathap Tharyan; Jacob Alexander; Clive Elliot Adams
Journal:  BMJ       Date:  2007-10-22

Review 9.  Benzodiazepines for schizophrenia.

Authors:  Markus Dold; Chunbo Li; Magdolna Tardy; Vesal Khorsand; Donna Gillies; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

Review 10.  Pharmacological control of acute agitation: focus on intramuscular preparations.

Authors:  Dan L Zimbroff
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.